Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 1.8T | 1.7T | 1.7T | 2.0T |
Cost of revenue | 1.5T | 1.4T | 1.5T | 1.7T |
Gross profit | 282.0B | 260.8B | 246.2B | 276.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 216.9B | 199.2B | 186.7B | 178.4B |
Other operating expenses | 327M | 1.4B | 3.2B | 3.4B |
Operating income | 64.7B | 60.1B | 56.4B | 95.1B |
Non operating interest income | ||||
Income | 7.4B | 7.1B | 8.4B | 8.9B |
Expense | 19.0B | 18.0B | 17.4B | 18.1B |
Other income expense | — | — | — | — |
Pretax income | 115.6B | 145.3B | 133.6B | 172.7B |
Tax provision | 12.9B | 22.0B | 20.7B | 29.0B |
Net income | 102.6B | 123.3B | 112.9B | 143.7B |
Basic EPS | — | 71.6 | 65.1 | 83.2 |
Diluted EPS | — | 71.5 | 65.0 | 83.0 |
Basic average shares | — | 1.7B | 1.7B | 1.7B |
Diluted average shares | — | 1.7B | 1.7B | 1.7B |
EBITDA | 205.9B | 207.8B | 190.2B | 230.2B |
Net income from continuing op. | 102.6B | 123.3B | 112.9B | 143.7B |
Minority interests | -2.7B | -3.1B | -2.9B | -2.4B |
Preferred stock dividends | 0 | 0 | 0 | 0 |